Jodie Morrison, CEO and President of Tokai Pharmaceuticals, is one of nearly 200 biopharma leaders who recently signed an open letter endorsing a Top Ten of best practices for advancing gender diversity, from the boardroom to the C-suite to the lab.

Previous articleNovo Nordisk to Invest $144M in U.K. Diabetes Research Center
Next articleCalithera and Incyte Agree on $53M Up-Front Deal for Clinical-Stage Arginase Inhibitor